Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Why Chinese silver prices differ from London and New York

By CPM Group There is some confusion in the investment community about silver prices in China, which are different from those quoted in London or New York. This is neither unusual nor unique. The current misunderstanding is preventing investors from fully grasping ...
Research | 13 days ago |

Minnesota helium project well positioned to help alleviate global shortage

By Marc Farrington In February this year, Pulsar Helium Inc (Pulsar) ( TSXV:PLSR ) announced extraordinarily high helium concentrations of up to 13.8% from its Jetstream No. 1 appraisal well drilled at its Topaz project in Minnesota. This has positioned Topaz as th...
Research | May 9, 2024 |

Regulatory clarity for market evolution: Canada’s position in global crypto industry

By Shaed Hashimkhial Canada is a forefront contender in financial innovation and cryptocurrency, with significant potential to dominate the digital asset sector. However, opinions vary within the industry; some advocate for clear legislation to support growth, whil...
Research | April 17, 2024 |

Buzz on the Bullboards: Highlights from Bay Street to Wall Street

As investors reflect on the past week’s market movements, it’s clear that some notable shifts have taken place in the Canadian and U.S. stock markets. On Bay Street, the Toronto Stock Exchange witnessed intriguing developments, while Wall S...
Jonathon Brown | April 4, 2024 |

Buzz on the Bullboards: Pulling gains out of volatile territory

As the global economy navigates uncertainties, investors have been watching the performance of key stock markets for insights into prevailing sentiment and economic health. Over the past week, the TSX and the trio of indices on Wall Street – the Dow Jones Industrial A...
Jonathon Brown | March 28, 2024 |

Buzz on the Bullboards: Bombardier, Baytex and Tilray turn heads

North American stocks have had a strong week. Markets on both sides of the border responded well to the U.S. Federal Reserve’s vote to hold interest rates between 5.25 per cent and 5.50 per cent for a fifth straight meeting. The central bank has kept r...
Jonathon Brown | March 21, 2024 |

Can NervGen keep a lid on explosive news?

Speculation of early “evidence” of successful proof-of-concept human trials sparks stock rallies Trial volunteers taking a placebo are offered the real deal in a follow-up trial as a “reward” The company&Clo...
Knox Henderson | March 20, 2024 |

Buzz on the Bullboards: Where volatility meets opportunity

It has been a wild ride for markets on Bay Street and Wall Street this week. Some indices hit lows not seen in nearly a year after a concerning inflation report, only to bounce back the next day. It is reporting season for many companies, and Stockhouse users seem...
Jonathon Brown | February 15, 2024 |

Is this stunning 'evidence' that NervGen has the goods?

This could be the signal that tiny NervGen Pharma Corp. (TSX-V:NGEN; OTCQX:NGENF) is destined to be one of the top performing biotech startup stocks this year. It came in a seemingly innocuous podcast interview about the company’s ongoing Phase 1b/2...
Knox Henderson | February 1, 2024 |

Buzz on the Bullboards: Good stocks with bad publicity

It was hedge fund legend Ray Dalio who said: “He who lives by the crystal ball will eat shattered glass.” Many stock markets may have seen a higher start to the year so far, but there is far from a universal sentiment across the sectors, with s...
Jonathon Brown | January 25, 2024 |
1 2 3 4 5 6 7 8 9 10 ...